Pakistan is a small country as compared to India and China; however it has substantial share in pharmaceutical market of Asia.
Pakistan is a strategically very important and big hub for import and export of basic and finished pharmaceutical products,
biologicals, herbal and homeopathic medicines, pharmaceutical equipments etc. In Pakistan, there are small as well as large
pharmaceutical units and they are following guidelines of European Medicines Agency (EMA), US Food and Drug Administration
(US-FDA) and International Conference on Harmonisation (ICH). Industry quality compliance ratio has improved over the years,
and we are producing high quality finished pharmaceutical products. There are six hundred ten pharmaceutical units in Pakistan;
these units are under the control of Drug regulatory Agency (National Regulation and Services Division). Employee of regulatory
bodies are getting training from US-FDA, EMA, and ICH etc. and improving current Good Manufacturing Practice. We have a
great potential in herbal medicines and we have explored the world best markets due to high quality. There are different research
institutes which are collaborating with industries and helping in conducting basic and clinical studies. The number of local and
multinational units in Pakistan has greatly increased in last 10 years, which are offering variety of pharmaceutical products and
due to competition the price of finished products are low and affordable for most of the people of Pakistan. However, still much
have to be achieved in order to reach the American and European pharmaceutical standard.
Jibran Khan has completed his undergraduate studies in Faculty of Pharmacy, Sindh University, Jamshoro, Pakistan in 2004 and postgraduate
studies in Department of Pharmacology, Faculty of Pharmacy, University of Karachi, Pakistan in 2007. He has got few years of experience of
working in regulatory compliance department of pharmaceutical industries. His research interest includes preclinical studies using in vivo animal
seizure models. He is also involved in clinical studies on the effects of new antiepileptic drugs in epileptic patients.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals